Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liraglutide in NSTEMI
NCT02577848Unknown
- Sponsor
- Chinese PLA General Hospital
- Start
- Oct 2015
- Primary completion
- Oct 2016
- Modality
- Peptides
- Countries
- 1
01
Overview
Randomised trial in Non-ST-segment elevation myocardial infarction (NSTEMI) comparing GLP-1 group with Placebo group (2 arms). Primary endpoint: Left Ventricular Ejection Fraction at 3 months. Status: unknown.
02
Drugs
03
Conditions
Non-ST-segment elevation myocardial infarction (NSTEMI)
Beyond the preview
Go deeper on NCT02577848.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02577848.